Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis (Q81753382)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18685917%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18685917%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

Stefan Presslauer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18685917%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Dejan Milosavljevic

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18685917%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Thomas Brücke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18685917%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Peter Bayer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18685917%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Wolfgang Hübl

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18685917%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

17 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18685917%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18685917%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

255

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18685917%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18685917%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

1508-1514

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18685917%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00415-008-0954-z

11 January 2020

exact match

0 references

cites work

[Cytoimmunological profile of cerebrospinal fluid in diagnosis of multiple sclerosis]

1 reference

12 December 2020

Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry

1 reference

12 December 2020

Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report

1 reference

12 December 2020

Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains

1 reference

12 December 2020

Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group

1 reference

12 December 2020

Free kappa light chains in multiple sclerosis spinal fluid

1 reference

12 December 2020

1 reference

12 December 2020

Free light chains in multiple sclerosis and infections of the CNS.

1 reference

12 December 2020

Anti-ganglioside antibodies and elevated CSF IgG levels in Guillain-Barre syndrome

1 reference

12 December 2020

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

1 reference

12 December 2020

Early Differential Diagnosis of Multiple Sclerosis Using a New Oligoclonal Band Test

1 reference

12 December 2020

Multiple sclerosis: free light chains in cerebrospinal fluid

1 reference

12 December 2020

Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.

1 reference

12 December 2020

Detection of oligoclonal free kappa chains in the absence of oligoclonal IgG in the CSF of patients with suspected multiple sclerosis.

1 reference

12 December 2020

IgG production within the central nervous system: a critical review of proposed formulae

1 reference

12 December 2020

Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis.

1 reference

12 December 2020

A study of oligoclonal band negative multiple sclerosis.

1 reference

12 December 2020

1 reference

12 December 2020

Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis

1 reference

12 December 2020

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

12 December 2020

Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness

1 reference

12 December 2020

The clinical significance of an intrathecal monoclonal immunoglobulin band: a follow-up study

1 reference

12 December 2020

Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.

1 reference

12 December 2020

Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria.

1 reference

12 December 2020

Oligoclonal IgG bands in cerebrospinal fluid. Principles for demonstration and interpretation based on findings in 1114 neurological patients

1 reference

12 December 2020

Intrathecal synthesis of free immunoglobulin light chains in multiple sclerosis

1 reference

12 December 2020

[Clinical usefulness of oligoclonal bands]

1 reference

12 December 2020

Free immunoglobulin light chains as target in the treatment of chronic inflammatory diseases

1 reference

12 December 2020

IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event

1 reference

12 December 2020

Free light chains in the CSF in multiple sclerosis

1 reference

12 December 2020

Kappa light chain predominance in serum and cerebrospinal fluid from human immunodeficiency virus type 1 (HIV-1)-infected patients

1 reference

12 December 2020

Multiple sclerosis progression in a natural history study: predictive value of cerebrospinal fluid free kappa light chains

1 reference

12 December 2020

Relative diagnostic value of cerebrospinal fluid kappa chains in MS: comparison with other immunoglobulin tests

1 reference

12 December 2020

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Free kappa and lambda light chain levels in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases

1 reference

12 December 2020

A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications

1 reference

12 December 2020